US 10,682,414 K1 (3,947th)
	Intranasal epinephrine formulations and methods for the treatment of disease
Edward T. Maggio; Pratik Shah; Richard Lowenthal; and Robert G. Bell
Assigned to AEGIS THERAPEUTICS, LLC
Trial No. IPR2021-01324, Aug. 12, 2021
Inter Partes Review Certificate for Patent 10,682,414, issued Jun. 16, 2020, Appl. No. 16/420,044, May 22, 2019
Inter Partes Review Certificate issued Apr. 8, 2025